TY  - JOUR
AU  - Levivien, Clara
AU  - Bottois, Cecile
AU  - Lopez Medina, Clementina
AU  - Dumas, Sophie
AU  - Hubert, Julien
AU  - Belo, Sephora
AU  - Roux, Christian
AU  - Conort, Ornella
AU  - Dougados, Maxime
PY  - 2021
DO  - 10.1016/j.jbspin.2021.105322
UR  - http://hdl.handle.net/10668/22291
T2  - Joint bone spine
AB  - Despite several studies proving the efficacy and safety of biosimilars compared with original drugs, switching to a biosimilar remains challenging when the decision is at the discretion of physicians with mandatory consent from patients. Educating...
LA  - en
PB  - Elsevier
KW  - Biologic disease-modifying anti-rheumatic drugs
KW  - Biosimilar pharmaceuticals
KW  - Clinical pharmacist
KW  - Adult
KW  - Biosimilar pharmaceuticals
KW  - Female
KW  - Humans
KW  - Male
KW  - Pharmacists
KW  - Referral and consultation
KW  - Retrospective studies
KW  - Rheumatic diseases
TI  - Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases.
TY  - research article
VL  - 89
ER  -